Skip to main content

Table 5 Odds Ratio and 95% CI from Multivariable analysis for 90 days bundle payment

From: Economics of the Management of Craniospinal Chordoma and Chondrosarcoma and the feasibility of the bundled payment model

   All patients (N = 2041)
   Group 1 Group 2 Group 3
   Skull and face Vertebral column Sacrum/ coccyx
Cofactor Category n = 1214 (69.1%) n = 297 (16.9%) n = 246 (14%)
Age +  10 year 0.9 (0.888, 0.97) 0.8 (0.827, 0.974) 0.8 (0.809, 0.966)
Gender Female vs Male 0.9 (0.847, 1.051) 1.1 (0.928, 1.444) 0.9 (0.761, 1.281)
Insurance Medicaid vs Commercial 0.5 (0.428, 0.692) 0.3 (0.174, 0.64) 0.4 (0.267, 0.838)
type Medicare vs Commercial 0.7 (0.646, 0.93) 0.8 (0.534, 1.297) 0.5 (0.27, 1.2)
Elixhauser Score 2 vs 1 1.1 (1.008, 1.363) 1.4 (1.084, 1.992) 1.3 (0.957, 1.79)
score Score 3 vs 1 1.4 (1.273, 1.696) 1.5 (1.149, 2.078) 1.4 (1.063, 1.92)
\